Joost D. de Bruijn founded Xpand Biotechnology BV and Progentix Orthobiology BV. Currently, he occupies the position of Chief Executive Officer at Kuros Biosciences Ltd., President & Chief Executive Officer for Xpand Biotechnology BV (a subsidiary of Kuros Biosciences Ltd.) and Chief Executive Officer at Progentix Orthobiology BV.
He is also Professor at Queen Mary University of London, Professor at the University of Twente and Professor at the University of London.
Joost D. de Bruijn previously occupied the position of Research Director at IsoTis SA.
He received a doctorate from the University of Leiden.